Cassiopea (CPPSF) Stock Price, News & Analysis

Company Overview

Cassiopea S.p.A. is a specialty pharmaceutical company focused on developing and commercializing prescription medicines for dermatological conditions. The company’s work has centered on innovative topical therapies for acne, androgenetic alopecia and other skin disorders.

Cassiopea’s lead product is Winlevi (clascoterone cream), a topical treatment approved in the United States for acne vulgaris. The company has also developed Breezula, a topical formulation of clascoterone investigated as a potential treatment for androgenetic alopecia, commonly known as pattern hair loss. Commercialization and development activities have involved partnerships with other pharmaceutical companies, including regional licensing arrangements.

Founded as a spin-off of Cosmo Pharmaceuticals, Cassiopea is based in Italy and has developed products for international dermatology markets, with its most advanced commercial activity in the United States. The company’s portfolio and corporate activities have been closely associated with Cosmo Pharmaceuticals, which has been its principal strategic partner and shareholder.

Key Stats

• Today's Range: $35.15 to $35.15
• 50-Day Range: $35.15 to $35.15
• 52-Week Range: $35.15 to $55.81
• Volume: N/A
• Average Volume: 608 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Biotechnology
• Sub-Industry: Biotechnology
• Current Symbol: OTCMKTS:CPPSF
• CIK: N/A
• Web: www.cassiopea.com
• Phone: (928) 689-1124
• Fax: N/A
• Employees: 11
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A